Dr. Neil Iyengar is a medical oncologist and clinical-translational researcher at Memorial Sloan Kettering Cancer Center (MSKCC) where he specializes in the care of patients with breast cancer. He also holds joint research appointments at the Rockefeller University Center for Clinical and Translational Science and Weill Cornell Medical College (WCMC) in New York. He received his undergraduate and medical degrees from the University of Illinois College of Medicine accelerated program in Chicago. He then went on to complete residency training in Internal Medicine at the University of Chicago followed by fellowship in medical oncology and hematology at MSKCC. Dr. Iyengar studies the role of obesity and inflammation in the development and progression of breast and several other cancers. He is Co-Leader of the MSKCC-WCMC Obesity & Cancer Working Group, a multi-institutional translational research team composed of laboratory scientists and clinicians. This group was the first to report obesity-related inflammation in the breast as a putative mechanism of carcinogenesis. Dr. Iyengar has been recognized for his work by several organizations including the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Breast Cancer Research Foundation, National Comprehensive Cancer Network, the American Association for Cancer Research, and others. He has been invited to present his work at international meetings and he has published several peer reviewed articles. Dr. Iyengar is now expanding his work to develop specific interventions, including diets, exercise programs, and medications, that target adipose tissue inflammation in order to protect patients from its harmful cancer-promoting effects.